Magnetic resonance techniques to monitor disease evolution and treatment trial outcomes in multiple sclerosis.

Although the correlations between magnetic resonance findings and long-term disease evolution range from poor to moderate, conventional precontrast and postcontrast magnetic resonance imaging provides sensitive and reliable measures to monitor multiple sclerosis activity over time. New pulse sequences with shorter acquisition times can be cost effective and reduce patients' discomfort. The application of other techniques that give more accurate estimates of disease burden and have higher pathological specificity might improve our understanding of multiple sclerosis evolution and provide new outcomes for monitoring clinical trials. Work is still needed to obtain optimal imaging of the spinal cord for multiple sclerosis diagnosis and monitoring.

[1]  Ludwig Kappos,et al.  Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis , 1999, The Lancet.

[2]  A J Thompson,et al.  Quantitative MRI in patients with clinically isolated syndromes suggestive of demyelination. , 1999, Neurology.

[3]  M Filippi,et al.  Comparison of MS clinical phenotypes using conventional and magnetization transfer MRI , 1999, Neurology.

[4]  M Filippi,et al.  Interscanner variation in brain MR lesion load measurements in multiple sclerosis using conventional spin-echo, rapid relaxation-enhanced, and fast-FLAIR sequences. , 1999, AJNR. American journal of neuroradiology.

[5]  M W Weiner,et al.  A serial study of new MS lesions and the white matter from which they arise , 1998, Neurology.

[6]  Ludwig Kappos,et al.  Placebo-controlled multicentre randomised trial of interferon β-1b in treatment of secondary progressive multiple sclerosis , 1998, The Lancet.

[7]  G. Ebers,et al.  Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis , 1998, The Lancet.

[8]  P M Matthews,et al.  Defining multiple sclerosis disease activity using MRI T2-weighted difference imaging. , 1998, Brain : a journal of neurology.

[9]  J. Caillé,et al.  Early structural changes in acute MS lesions assessed by serial magnetization transfer studies , 1998, Neurology.

[10]  M. Horsfield,et al.  A multi-centre longitudinal study comparing the sensitivity of monthly MRI after standard and triple dose gadolinium-DTPA for monitoring disease activity in multiple sclerosis. Implications for phase II clinical trials. , 1998, Brain : a journal of neurology.

[11]  J. Daurès,et al.  Unselected brain 0.5-T MR imaging: comparison of lesion detection and characterization with three T2-weighted sequences. , 1998, Radiology.

[12]  G J Barker,et al.  Serial magnetization transfer imaging to characterize the early evolution of new MS lesions , 1998, Neurology.

[13]  M. Filippi,et al.  Magnetization transfer ratios of multiple sclerosis lesions with variable durations of enhancement , 1998, Journal of the Neurological Sciences.

[14]  D. Arnold,et al.  In vivo differentiation of astrocytic brain tumors and isolated demyelinating lesions of the type seen in multiple sclerosis using 1H magnetic resonance spectroscopic imaging , 1998, Annals of neurology.

[15]  M. Rovaris,et al.  MRI evolution of new MS lesions enhancing after different doses of gadolinium , 1998, Acta neurologica Scandinavica.

[16]  P M Matthews,et al.  Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study. , 1998, Brain : a journal of neurology.

[17]  M Rovaris,et al.  A longitudinal brain MRI study comparing the sensitivities of the conventional and a newer approach for detecting active lesions in multiple sclerosis , 1998, Journal of the Neurological Sciences.

[18]  H. Adams,et al.  Assessing information in T2-weighted MRI scans from secondary progressive MS patients , 1998, Neurology.

[19]  G. Barker,et al.  Spinal cord atrophy and disability in MS , 1998, Neurology.

[20]  G. Barker,et al.  Precision and reliability for measurement of change in MRI lesion volume in multiple sclerosis: a comparison of two computer assisted techniques , 1998, Journal of neurology, neurosurgery, and psychiatry.

[21]  Massimo Filippi,et al.  Quantitative volumetric analysis of brain magnetic resonance imaging from patients with multiple sclerosis , 1998, Journal of the Neurological Sciences.

[22]  M. Horsfield,et al.  A one year study of new lesions in multiple sclerosis using monthly gadolinium enhanced MRI: Correlations with changes of T2 and magnetization transfer lesion loads , 1998, Journal of the Neurological Sciences.

[23]  M. Filippi,et al.  Triple dose of gadolinium-DTPA increases the sensitivity of spinal cord MRI in detecting enhancing lesions in multiple sclerosis , 1998, Journal of the Neurological Sciences.

[24]  J K Udupa,et al.  Correlation of volumetric magnetization transfer imaging with clinical data in MS , 1998, Neurology.

[25]  J K Udupa,et al.  Comparison of T2 lesion volume and magnetization transfer ratio histogram analysis and of atrophy and measures of lesion burden in patients with multiple sclerosis. , 1998, AJNR. American journal of neuroradiology.

[26]  F. Fera,et al.  Randomized trial comparing two different high doses of methylprednisolone in MS A clinical and MRI study , 1998, Neurology.

[27]  S. Rombouts,et al.  Visual activation patterns in patients with optic neuritis , 1998, Neurology.

[28]  M Rovaris,et al.  Relation between MR abnormalities and patterns of cognitive impairment in multiple sclerosis , 1998, Neurology.

[29]  C. Wolfson,et al.  Multiple sclerosis of the spinal cord: diagnosis and follow-up with contrast-enhanced MR and correlation with clinical activity. , 1998, AJNR. American journal of neuroradiology.

[30]  M Filippi,et al.  Magnetization transfer changes in the normal appering white matter precede the appearance of enhancing lesions in patients with multiple sclerosis , 1998, Annals of neurology.

[31]  C. V. Jensen,et al.  Intravenous immunoglobulin G reduces MRI activity in relapsing multiple sclerosis , 1998, Neurology.

[32]  G. Comi,et al.  Magnetization transfer ratios in multiple sclerosis lesions enhancing after different doses of gadolinium , 1998, Neurology.

[33]  F. Barkhof,et al.  Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis , 1998, Neurology.

[34]  J. K. Udupa,et al.  Isolated U-fiber involvement in MS , 1998, Neurology.

[35]  Marco Rovaris,et al.  The effect of repositioning on brain MRI lesion load assessment in multiple sclerosis: reliability of subjective quality criteria , 1998, Journal of Neurology.

[36]  T. Yousry,et al.  Common variable immunodeficiency leading to spinal subacute combined degeneration monitored by MRI , 1998, Journal of neurology, neurosurgery, and psychiatry.

[37]  M. Sormani,et al.  Effect of copolymer-1 on serial gadolinium-enhanced MRI in relapsing remitting multiple sclerosis , 1998, Neurology.

[38]  J A Frank,et al.  Guidelines for using quantitative measures of brain magnetic resonance imaging abnormalities in monitoring the treatment of multiple sclerosis , 1998, Annals of neurology.

[39]  F. Barkhof,et al.  Patterns of lesion development in multiple sclerosis: longitudinal observations with T1-weighted spin-echo and magnetization transfer MR. , 1998, AJNR. American journal of neuroradiology.

[40]  M Rovaris,et al.  Intraobserver and interobserver variability in measuring changes in lesion volume on serial brain MR images in multiple sclerosis. , 1998, AJNR. American journal of neuroradiology.

[41]  F. Barkhof,et al.  Brain and spinal cord abnormalities in multiple sclerosis. Correlation between MRI parameters, clinical subtypes and symptoms. , 1998, Brain : a journal of neurology.

[42]  A. Thompson,et al.  The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10-year follow-up. , 1998, Brain : a journal of neurology.

[43]  I. Moseley,et al.  Asymptomatic spinal cord lesions in clinically isolated optic nerve, brain stem, and spinal cord syndromes suggestive of demyelination , 1998, Journal of neurology, neurosurgery, and psychiatry.

[44]  F. Barkhof,et al.  Correlations between monthly enhanced MRI Lesion rate and changes in T2 Lesion volume in multiple sclerosis , 1998, Annals of neurology.

[45]  M. Horsfield,et al.  Effect of steroids on Gd‐enhancing lesions before and during recombinant beta interferon la treatment in relapsing remitting multiple sclerosis , 1998, Neurology.

[46]  M Filippi,et al.  Characteristics of chronic MS lesions in the cerebrum, brainstem, spinal cord, and optic nerve on T1‐‐‐weighted MRI , 1998, Neurology.

[47]  G. Comi,et al.  Intraobserver and interobserver variability in schemes for estimating volume of brain lesions on MR images in multiple sclerosis. , 1998, AJNR. American journal of neuroradiology.

[48]  F. Barkhof,et al.  Sagittal MR of multiple sclerosis in the spinal cord: fast versus conventional spin-echo imaging. , 1998, AJNR. American journal of neuroradiology.

[49]  R. Tarducci,et al.  1H-MRS in patients with multiple sclerosis undergoing treatment with interferon β-1a: results of a preliminary study , 1998, Journal of neurology, neurosurgery, and psychiatry.

[50]  A. Thompson,et al.  Secondary progressive multiple sclerosis: the relationship between short-term MRI activity and clinical features. , 1998, Brain : a journal of neurology.

[51]  A J Thompson,et al.  MRI lesion volume measurement in multiple sclerosis and its correlation with disability: a comparison of fast fluid attenuated inversion recovery (fFLAIR) and spin echo sequences , 1998, Journal of neurology, neurosurgery, and psychiatry.

[52]  Jeanelle Sheeder,et al.  Magnetic resonance studies of intramuscular interferon β–1a for relapsing multiple sclerosis , 1998 .

[53]  J S Wolinsky,et al.  Serial proton magnetic resonance spectroscopic imaging, contrast‐enhanced magnetic resonance imaging, and quantitative lesion volumetry in multiple sclerosis , 1998, Annals of neurology.

[54]  A. Thompson,et al.  Exploratory treatment trials in multiple sclerosis using MRI: sample size calculations for relapsing-remitting and secondary progressive subgroups using placebo controlled parallel groups , 1998, Journal of neurology, neurosurgery, and psychiatry.

[55]  S. Reingold,et al.  The role of magnetic resonance techniques in understanding and managing multiple sclerosis. , 1998, Brain : a journal of neurology.

[56]  P M Matthews,et al.  Imaging axonal damage of normal-appearing white matter in multiple sclerosis. , 1998, Brain : a journal of neurology.

[57]  H. Hartung,et al.  Matrix metalloproteinase-9 and -7 are regulated in experimental autoimmune encephalomyelitis. , 1998, Brain : a journal of neurology.

[58]  G. Barker,et al.  1H magnetic resonance spectroscopy of chronic cerebral white matter lesions and normal appearing white matter in multiple sclerosis , 1997, Journal of neurology, neurosurgery, and psychiatry.

[59]  M Rovaris,et al.  Improving interobserver variation in reporting gadolinium-enhanced MRI lesions in multiple sclerosis , 1997, Neurology.

[60]  G. Comi,et al.  Serial contrast-enhanced MR in patients with multiple sclerosis and varying levels of disability. , 1997, AJNR. American journal of neuroradiology.

[61]  A J Thompson,et al.  Multiple sclerosis lesion detection in the brain: A comparison of fast fluid-attenuated inversion recovery and conventional T2-weighted dual spin echo , 1997, Neurology.

[62]  G J Barker,et al.  Sensitivity of contrast enhanced MRI in multiple sclerosis. Effects of gadolinium dose, magnetization transfer contrast and delayed imaging. , 1997, Brain : a journal of neurology.

[63]  P. Scheltens,et al.  MR of the spinal cord in multiple sclerosis: relation to clinical subtype and disability. , 1997, AJNR. American journal of neuroradiology.

[64]  G. Barker,et al.  Serial magnetisation transfer ratios in gadolinium-enhancing lesions in multiple sclerosis , 1997, Journal of Neurology.

[65]  M. Rovaris,et al.  Sensitivity and Reproducibility of Fast‐FLAIR, FSE, and TGSE Sequences for the MRI Assessment of Brain Lesion Load in Multiple Sclerosis: A Preliminary Study , 1997, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[66]  L Bozzao,et al.  Fast spin-echo and fast fluid-attenuated inversion-recovery versus conventional spin-echo sequences for MR quantification of multiple sclerosis lesions. , 1997, AJNR. American journal of neuroradiology.

[67]  A comparison of conventional and fast spin-echo sequences for the measurement of lesion load in multiple sclerosis using a semi-automated contour technique , 1997, Neuroradiology.

[68]  A. Thompson,et al.  Imaging of the spinal cord and brain in multiple sclerosis: a comparative study between fast flair and fast spin echo , 1997, Journal of Neurology.

[69]  J Foong,et al.  Executive function in multiple sclerosis. The role of frontal lobe pathology. , 1997, Brain : a journal of neurology.

[70]  M. Horsfield,et al.  Spinal cord MRI in multiple sclerosis with multicoil arrays: a comparison between fast spin echo and fast FLAIR. , 1996, Journal of neurology, neurosurgery, and psychiatry.

[71]  A J Thompson,et al.  Progressive cerebral atrophy in multiple sclerosis. A serial MRI study. , 1996, Brain : a journal of neurology.

[72]  R I Grossman,et al.  Quantitative volumetric magnetization transfer analysis in multiple sclerosis: Estimation of macroscopic and microscopic disease burden , 1996, Magnetic resonance in medicine.

[73]  D. Prayer,et al.  Spinal cord lesions in patients with multiple sclerosis: comparison of MR pulse sequences. , 1996, AJNR. American journal of neuroradiology.

[74]  A. Thompson,et al.  Spinal MRI in patients with suspected multiple sclerosis and negative brain MRI. , 1996, Brain : a journal of neurology.

[75]  W. I. McDonald,et al.  Serial gadolinium-enhanced MRI of the brain and spinal cord in early relapsing-remitting multiple sclerosis , 1996, Neurology.

[76]  M Filippi,et al.  Comparison of triple dose versus standard dose gadolinium-DTPA for detection of MRI enhancing lesions in patients with MS , 1996, Neurology.

[77]  G. Barker,et al.  MRI dynamics of brain and spinal cord in progressive multiple sclerosis. , 1996, Journal of neurology, neurosurgery, and psychiatry.

[78]  R. Knobler,et al.  Multiple sclerosis in the spinal cord: MR appearance and correlation with clinical parameters. , 1995, Radiology.

[79]  M Filippi,et al.  A Magnetization Transfer Imaging Study of Normal-Appearing White Matter in Multiple Sclerosis , 1995, Neurology.

[80]  J. Grafman,et al.  Relationship between frontal lobe lesions and Wisconsin Card Sorting Test performance in patients with multiple sclerosis , 1994, Neurology.

[81]  A. Thompson,et al.  Spinal cord MRI using multi‐array coils and fast spin echo , 1993, Neurology.

[82]  B E Kendall,et al.  Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Pathogenetic and clinical implications. , 1990, Brain : a journal of neurology.